🔗 Share this article

This year's Nobel Prize in medical science has been awarded for revolutionary findings that illuminate how the body's defense network targets dangerous pathogens while protecting the healthy tissues.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Fred Ramsdell—received this honor.

The work identified specialized "sentinels" within the defense system that eliminate malfunctioning defense cells that could harming the body.

These discoveries are now paving the way for innovative therapies for autoimmune diseases and cancer.

These winners will share a prize fund valued at 11 million SEK.

Decisive Discoveries

"The research has been essential for comprehending how the body's defenses functions and the reason we don't all develop serious autoimmune diseases," stated the head of the award panel.

The trio's research address a core mystery: In what way does the immune system defend us from numerous infections while keeping our own tissues unharmed?

The body's protection system uses white blood cells that scan for indicators of disease, including pathogens and germs it has never encountered.

These cells employ sensors—called receptors—that are generated randomly in countless combinations.

That provides the defense network the ability to fight a wide array of invaders, but the randomness of the process unavoidably creates immune cells that can target the body.

Protectors of the Body

Scientists earlier understood that a portion of these harmful defense cells were destroyed in the thymus—where white blood cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the body's "security guards"—which patrol the system to disarm any defenders that assault the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "These findings have laid the foundation for a novel area of research and accelerated the creation of new therapies, for instance for cancer and immune disorders."

Regarding malignancies, regulatory T-cells block the body from fighting the growth, so research are aimed at lowering their numbers.

For autoimmune diseases, experiments are testing increasing regulatory T-cells so the organism is no longer under attack. A similar approach could also be effective in reducing the chances of transplanted organ failure.

Pioneering Studies

Prof Shimon Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus removed, leading to autoimmune disease.

The researcher showed that introducing immune cells from healthy animals could stop the illness—suggesting there was a system for blocking defenders from attacking the host.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were investigating an genetic autoimmune disease in mice and people that resulted in the discovery of a genetic factor critical for the way regulatory T-cells function.

"The groundbreaking research has revealed how the immune system is kept in check by T-reg cells, stopping it from accidentally attacking the healthy cells," commented a leading physiology specialist.

"This work is a remarkable illustration of how basic physiological research can have far-reaching implications for public health."